| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.374 | 0 | 0 | 0 | 7.655 | 18.466 | 24.029 | 31.252 | 25.184 |
| Total Income - EUR | - | 1.374 | 0 | 0 | 0 | 7.664 | 18.466 | 24.038 | 31.252 | 26.190 |
| Total Expenses - EUR | - | 1.227 | 450 | 0 | 0 | 3.907 | 9.277 | 20.908 | 27.557 | 29.731 |
| Gross Profit/Loss - EUR | - | 147 | -450 | 0 | 0 | 3.757 | 9.189 | 3.130 | 3.695 | -3.542 |
| Net Profit/Loss - EUR | - | 106 | -450 | 0 | 0 | 3.527 | 8.818 | 2.924 | 3.429 | -3.764 |
| Employees | - | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medgeostad Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 40 | 40 | 39 | 38 | 37 | 8.091 | 31.938 | 31.515 | 17.102 |
| Current Assets | - | 252 | 0 | 0 | 0 | 3.989 | 5.145 | 10.148 | 9.382 | 1.064 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | 3.316 | 4.778 | 9.218 | 7.183 | 101 |
| Cash | - | 252 | 0 | 0 | 0 | 673 | 367 | 930 | 2.198 | 963 |
| Shareholders Funds | - | 150 | -302 | -296 | -291 | 3.242 | 11.988 | 14.949 | 18.333 | 9.739 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 142 | 341 | 335 | 329 | 785 | 1.247 | 27.137 | 22.563 | 8.427 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Medgeostad Srl